Na, I I <br/><br/>
Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2011 
 - 2068-2072 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Female<br/>Fluorodeoxyglucose F18--pharmacokinetics<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Positron-Emission Tomography<br/>Radiopharmaceuticals--pharmacokinetics<br/>Retrospective Studies<br/>Smoking--adverse effects